Caribou Biosciences Files 2025 Proxy Statement
Ticker: CRBU · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: CRBU
TL;DR
Caribou Bio (CRBU) filed its proxy statement for the 2025 annual meeting. Vote your shares!
AI Summary
Caribou Biosciences, Inc. filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its 2025 Annual Meeting of Stockholders. The filing covers the fiscal year ending December 31, 2024, and details matters to be voted on by shareholders, including the election of directors and other corporate governance items. The company is based in Berkeley, CA.
Why It Matters
This filing provides shareholders with crucial information regarding corporate governance and voting matters, enabling them to make informed decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently introduce new financial risks.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the financial information discussed in the proxy statement.)
- 2025 — Annual Meeting Year (The year for which the shareholder meeting is being held.)
Key Players & Entities
- Caribou Biosciences, Inc. (company) — Registrant
- 2025 Annual Meeting of Stockholders (event) — Subject of the proxy statement
- April 25, 2025 (date) — Filing date
- December 31, 2024 (date) — Fiscal year end
- Berkeley, CA (location) — Company headquarters
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information and solicit their votes for the 2025 Annual Meeting of Stockholders, including the election of directors and other corporate matters.
When was this definitive proxy statement filed with the SEC?
This definitive proxy statement was filed with the SEC on April 25, 2025.
What fiscal year does this filing pertain to?
This filing pertains to the fiscal year ending on December 31, 2024.
Where is Caribou Biosciences, Inc. located?
Caribou Biosciences, Inc. is located at 2929 7th Street, Suite 105, Berkeley, CA 94710.
What type of company is Caribou Biosciences, Inc. classified as?
Caribou Biosciences, Inc. is classified under the Standard Industrial Classification code 2836, which is for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Caribou Biosciences, Inc. (CRBU).